Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study)

Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study)

INTRODUCTION: Despite improvements in the management of chronic hepatitis B (CHB), risk of cirrhosis and hepatocellular carcinoma remains. While hepatitis B surface antigen loss is the optimal end point, safe discontinuation of nucleos(t)ide analog (NA) therapy is controversial because of the possib...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Grishma Hirode, Bettina E. Hansen, Chien‐Hung Chen, Tung‐Hung Su, Grace Lai‐Hung Wong, Wai‐Kay Seto, Stijn Van Hees, Μargarita Papatheodoridi, Sylvia M. Brakenhoff, Sabela Lens, Hannah Choi, Rong‐Nan Chien, Jordan J. Feld, Xavier Forns, Milan J. Sonneveld, George Papatheodoridis, Thomas Vanwolleghem, Man‐Fung Yuen, Henry Lik‐Yuen Chan, Jia‐Horng Kao, Yao‐Chun Hsu, Markus Cornberg, Wen‐Juei Jeng, Harry L.A. Janssen
Formato: Artigo
Idioma:inglés
Publicado: 2023
Acceso en liña:https://doi.org/10.14309/ajg.0000000000002203
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Internet

https://doi.org/10.14309/ajg.0000000000002203

Títulos similares